The prevalence of anaemia (Hb<120 g/L) in the study population was 18.5% (28/151) in cases with Vitamin B12<150 pmol/L, and 16.0% (122/762) in cases with levels ≥150 pmol/L (p = 0.5). This evidence concerns the gene GSTM1 and anemia.